|
1
|
Jennette JC, Falk RJ, Bacon PA, Basu N,
Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen
EC, et al: 2012 revised international Chapel Hill consensus
conference nomenclature of vasculitides. Arthritis Rheum. 65:1–11.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mohammad AJ, Jacobsson LT, Mahr AD,
Sturfelt G and Segelmark M: Prevalence of Wegener's granulomatosis,
microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss
syndrome within a defined population in southern Sweden.
Rheumatology. 46:1329–1337. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mohammad AJ, Jacobsson LT, Westman KW,
Sturfelt G and Segelmark M: Incidence and survival rates in
Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss
syndrome and polyarteritis nodosa. Rheumatology (Oxford).
48:1560–1565. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Watts RA, Lane SE, Scott DG, Koldingsnes
W, Nossent H, Gonzalez-Gay MA, Garcia-Porrua C and Bentham GA:
Epidemiology of vasculitis in Europe. Ann Rheum Dis. 60:1156–1157.
2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Greco A, De Virgilio A, Rizzo MI, Gallo A,
Magliulo G, Fusconi M, Ruoppolo G, Tombolini M, Turchetta R and de
Vincentiis M: Microscopic polyangiitis: Advances in diagnostic and
therapeutic approaches. Autoimmun Rev. 14:837–844. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
van der Woude FJ, Rasmussen N, Lobatto S,
Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK and
The TH: Autoantibodies against neutrophils and monocytes: tool for
diagnosis and marker of disease activity in Wegener's
granulomatosis. Lancet. 1:425–429. 1985.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jennette JC, Falk RJ, Andrassy K, Bacon
PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg
CG, et al: Nomenclature of systemic vasculitides. Proposal of an
international consensus conference. Arthritis Rheum. 37:187–192.
1994.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jennette JC and Falk RJ: Antineutrophil
cytoplasmic autoantibodies and associated diseases: A review. Am J
Kidney Dis. 15:517–529. 1990.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Savige J, Gillis D, Benson E, Davies D,
Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B,
et al: International consensus statement on testing and reporting
of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol.
111:507–513. 1999.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bossuyt X, Cohen Tervaert JW, Arimura Y,
Blockmans D, Flores-Suárez LF, Guillevin L, Hellmich B, Jayne D,
Jennette JC, Kallenberg CGM, et al: Revised 2017 international
consensus on testing of ANCAs in granulomatosis with polyangiitis
and microscopic polyangiitis. Nat Rev Rheumatol. 13:683–692.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hagen EC, Daha MR, Hermans J, Andrassy K,
Csernok E, Gaskin G, Lesavre P, Lüdemann J, Rasmussen N, Sinico RA,
et al: Diagnostic value of standardized assays for anti-neutrophil
cytoplasmic antibodies in idiopathic systemic vasculitis for the
EC/BCR project for ANCA assay standardisation. Kidney Int.
53:743–753. 1998.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sablé-Fourtassou R, Cohen P, Mahr A,
Pagnoux C, Mouthon L, Jayne D, Blockmans D, Cordier JF, Delaval P,
Puechal X, et al: Antineutrophil cytoplasmic antibodies and the
Churg-Strauss syndrome. Ann Intern Med. 143:632–638.
2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bossuyt X: Serologic markers in
inflammatory bowel disease. Clin Chem. 52:171–181. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Terjung B: Anti-neutrophil antibodies in
primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol.
15:629–642. 2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Terjung B, Bogsch F, Klein R, Söhne J,
Reichel C, Wasmuth JC, Beuers U, Sauerbruch T and Spengler U:
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis
using ROC-and multivariate regression analysis. Eur J Med Res.
9:439–448. 2004.PubMed/NCBI
|
|
16
|
Roozendaal C, de Jong MA, van den Berg AP,
van Wijk RT, Limburg PC and Kallenberg CG: Clinical significance of
anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver
diseases. J Hepatol. 32:734–741. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Terjung B, Worman HJ, Herzog V, Sauerbruch
T and Spengler U: Differentiation of antineutrophil nuclear
antibodies in inflammatory bowel and autoimmune liver diseases from
antineutrophil cytoplasmic antibodies (p-ANCA) using
immunofluorescence microscopy. Clin Exp Immunol. 126:37–46.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Humbert S, Guilpain P, Puéchal X, Terrier
B, Rivière S, Mahr A, Pagnoux C, Bagnères D, Cordier JF, Le Quellec
A, et al: Inflammatory bowel diseases in anti-neutrophil
cytoplasmic antibody-associated vasculitides: 11 retrospective
cases from the French vasculitis study group. Rheumatology
(Oxford). 54:1970–1975. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Philipponnet C, Garrouste C, Le Guenno G,
Cartery C, Guillevin L, Boffa JJ and Heng AE: Antineutrophilic
cytoplasmic antibody-associated vasculitis and malignant
hemopathies, a retrospective study of 16 cases. Joint Bone Spine.
84:51–57. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Weiner M and Segelmark M: The clinical
presentation and therapy of diseases related to anti-neutrophil
cytoplasmic antibodies (ANCA). Autoimmune Rev. 15:978–982.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Langlois V, Lesourd A, Girszyn N, Ménard
JF, Levesque H, Caron F and Marie I: Antineutrophil cytoplasmic
antibodies associated with infectious endocarditis. Medicine
(Baltimore). 95(e2564)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Flores-Suárez LF, Cabiedes J, Villa AR,
van der Woude FJ and Alcocer-Varela J: Prevalence of antineutrophil
cytoplasmic autoantibodies in patients with tuberculosis.
Rheumatology (Oxford). 42:223–229. 2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Suppiah R, Robson JC, Grayson PC, Ponte C,
Craven A, Khalid S, Judge A, Hutchings A, Merkel PA, Luqmani RA, et
al: 2022 American college of rheumatology/european alliance of
associations for rheumatology classification criteria for
microscopic polyangiitis. Ann Rheum Dis. 81:321–326.
2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
EULAR Textbook on Rheumatic diseases.
Third Edition. BMJ Publishing Group, London, 2018.
|
|
25
|
Shchegoleva E, Zykova A, Bulanov N,
Meshkov A, Novikov P and Moiseev S: Lung damage in patients with
microscopic polyangiitis. Ann Rheumatic Dis. 77(766)2018.
|
|
26
|
Tzelepis GE, Kokosi M, Tzioufas A, Toya
SP, Boki KA, Zormpala A and Moutsopoulos HM: Prevalence and outcome
of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J.
36:116–121. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Huang H, Wang YX, Jiang CG, Liu J, Li J,
Xu K and Xu ZJ: A retrospective study of microscopic polyangiitis
patients presenting with pulmonary fibrosis in China. BMC Pulm Med.
14(8)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fernandez Casares M, Gonzalez A, Fielli M,
Caputo F, Bottinelli Y and Zamboni M: Microscopic polyangiitis
associated with pulmonary fibrosis. Clin Rheumatol. 34:1273–1277.
2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Guillevin L, Durand-Gasselin B, Cevallos
R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P and
Jarrousse B: Microscopic polyangiitis: Clinical and laboratory
findings in eighty-five patients. Arthritis Rheum. 42:421–430.
1999.PubMed/NCBI View Article : Google Scholar
|
